520 related articles for article (PubMed ID: 6937237)
1. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
Bodner SM; Casavant CH; McHugh TM; Stites DP
Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
4. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
Han T; Gomez GA; Minowada J
Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of leukemia cell terminal transferase measurements.
McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
7. Blast crisis of chronic myelogenous leukemia. Morphologic and immunological features.
Nemoto K; Honma K; Fukuda T; Ohnishi Y
Acta Pathol Jpn; 1986 Oct; 36(10):1441-54. PubMed ID: 3541490
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.
Kalwinsky DK; Weatherred WH; Dahl GV; Bowman WP; Melvin SL; Coleman MS; Bollum FJ
Cancer Res; 1981 Jul; 41(7):2877-81. PubMed ID: 7018672
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia.
Catovsky D; O'Brien M; Cherchi M; Benavides I
Boll Ist Sieroter Milan; 1978 Jul; 57(3):344-54. PubMed ID: 282904
[TBL] [Abstract][Full Text] [Related]
10. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
11. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
14. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
15. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
16. Chronic myelocytic leukemia terminating in blast cell crisis with lymphoblastic characteristics.
Walters TR; Minowada J; Tsubota T; Kataoka K; Han T
Pediatrics; 1978 Nov; 62(5):795-800. PubMed ID: 281667
[TBL] [Abstract][Full Text] [Related]
17. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
[TBL] [Abstract][Full Text] [Related]
18. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
[TBL] [Abstract][Full Text] [Related]
19. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
20. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]